Feedback / Questions
mezagitamab (TAK-079) - Takeda
https://investors.xoma.com/news-events/press-releases/detail/493/xoma-royalty-and-takeda-execute-strategic-royalty-sharing
Dec 30, 2025
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next